Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totaling 6,564 shares, a growth of 256.5% from the December 31st total of 1,841 shares. Based on an average daily volume of 324,047 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 324,047 shares, the days-to-cover ratio is currently 0.0 days.

Revolution Medicines Stock Performance

Shares of Revolution Medicines stock traded up $0.19 on Wednesday, reaching $2.14. 1,862 shares of the company were exchanged, compared to its average volume of 259,818. The stock’s 50 day moving average price is $1.42 and its 200-day moving average price is $0.69. Revolution Medicines has a 1-year low of $0.03 and a 1-year high of $3.59.

About Revolution Medicines

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.